News in brief: Tofacitinib salvage therapy in ASUC; Virtual FOBT clinics offer faster time to colonoscopy; Gender disparity in citations a career barrier for women in medicine

Tofacitinib suceeds as salvage therapy in ASUC High-dose tofacitinib may have a role as salvage therapy following non-response to infliximab in patients with steroid-refractory acute severe ulcerative colitis (ASUC), Australian clinicians have suggested. Dr Robert Gilmore and colleagues at the Department of Gastroenterology, Austin Health, Melbourne, have reported a case series in which four out of ...

Already a member?

Login to keep reading.

© 2021 the limbic